Inhibition of prostagrandin synthesis for the treatment of Duchenne musclar dystrophy
Phase 1
- Conditions
- Duchenne muscular dystrophy
- Registration Number
- JPRN-UMIN000009307
- Lead Sponsor
- Kobe University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Male
- Target Recruitment
- 6
Inclusion Criteria
Not provided
Exclusion Criteria
Hypersensitivity to aspirin cases with gastric ulcer cases with hematological abnormality cases with beeding tendency Cases with heart, liver or kidney dysfunction Cases with chicken pox or influenza Cases administered beta-bloclker, ACE inhibitor, warfarin, steroid
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method